13V. Kawano MV Hirano T, Matsude T, etai. Autocrine generation 
and requirement of BSF-2/.IL-6 for human multiple myelomas. Nature 
1988; 332:83-85. 
14. Klein B, Zhang X-G, Jourdan M, et al. Paracrine rather than 
autocrine regulation-' of myeloma— cell - growth and differentiation 
by IL-6. Blood 1989; 73:517-526. 
15. Zhang XG, Klein B , Bataille R. Interleukin-6 is a potent 
myeloma-cell growth factor in patients with aggressive multiple 
myeloma. Blood 1989; 74:11-13. 
16. Sakai A, Kawano M, Kuramoto A. Interleukin-6 produced by 
renal cell carcinoma cells and progression of multiple myeloma. N 
E J M 1991; 324:1893. 
1,-. Klein B, Wijdenes J, Zhang X-G, et al. Murine 
anti-interleukin-6 monoclonal antibody therapy for a patient with 
plasma cell leukemia. Blood 1991; 78:1198-1204. 
18. Armitage JO. Bone marrow tranplantation in patients with 
lymphoma. Blood 1989; 73:1749-1758. 
19. Bargolie B, Epstein J, Selvanayagam P, Alexanian R. Plasma 
cell myeloma-new biological insights and advances in therapy. 
Blood 1989; 73:865-879. 
20. Elias A, Mazanet R, Wheeler C, et al. Peripheral blood 
progenitor cells (pbpc) : two protocols using GM-CSF potentiated 
progenitor cell collection. In: Dicke K, Armitage JO, 
Dicke-Evinger MJ, eds. Autologous Bone Marrow Transplantation: 
Proceedings of the Fifth International Symposium. Omaha: 
University of Nebraska, 1991:875-879. 
21. Gianni AM, Bregni M, Siena S, et al. Rapid and complete 
hemopoietic reconstitution following combined transplantation of 
autologous blood and bone marrow cells. A changing role for high 
dose chemo-radiotherapy? Reinatol' Oncol 1989; 7:139-148. 
22. - Hodgson GS, Bradley TR. Properties of haematopoeitc stem 
cells surviving 5-f luoruracil treatment: evidence for a 
pre-GFU-S cell? Nature 1979; 281:381-382. 
23. Mandelli F, Avisati G, Amadori S, et al. Maintenance 
treatment with recombinant interferon alpha-2b in patients with 
multiple myeloma responding to conventional induction 
chemotherapy . ' N Engl J Med 1990; 322:1430-1434. 
24. Attal M, Huguet F, Schlaifer D, et al. Intensive combined 
therapy for previously untreated aggressive. myeloma. Blood 1991; 
submitted: 
Recombinant DNA Research, Volume 16 
[63] 
